These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8580834)

  • 1. Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
    Suki S; Swan F; Tucker S; Fritsche HA; Redman JR; Rodriguez MA; McLaughlin P; Romaguera J; Hagemeister FB; Velasquez WS
    Leuk Lymphoma; 1995 Jun; 18(1-2):87-92. PubMed ID: 8580834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
    Avilés A; Zepeda G; Díaz-Maqueo JC; Rodriguez L; Guzmán R; García EL; Talavera A
    Leuk Lymphoma; 1992 May; 7(1-2):135-8. PubMed ID: 1472924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma.
    Milanovic N; Matkovic S; Ristic D; Jelic S; Petrovic M
    J BUON; 2012; 17(3):497-501. PubMed ID: 23033288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
    Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
    Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
    Swan F; Velasquez WS; Tucker S; Redman JR; Rodriguez MA; McLaughlin P; Hagemeister FB; Cabanillas F
    J Clin Oncol; 1989 Oct; 7(10):1518-27. PubMed ID: 2674337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
    Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
    Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma.
    Procházka V; Faber E; Raida L; Langová K; Indrák K; Papajík T
    Leuk Lymphoma; 2012 Jul; 53(7):1306-10. PubMed ID: 22263569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
    Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
    Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biological significance of serum tumor markers in adult T-cell leukemia.
    Sadamori N
    Leuk Lymphoma; 1996 Aug; 22(5-6):415-9. PubMed ID: 8882954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
    Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C
    Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study.
    Yamamoto M; Watanabe K; Fukuda T; Miura O
    Anticancer Res; 2017 May; 37(5):2655-2662. PubMed ID: 28476841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis.
    Hagberg H; Glimelius B; Gronowitz S; Killander A; Källander C; Schröder T
    Scand J Haematol; 1984 Jul; 33(1):59-67. PubMed ID: 6379852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-2 microglobulin and lactate dehydrogenase levels are useful prognostic markers in early stage primary gastric lymphoma.
    Avilés A; Narváez BR
    Clin Lab Haematol; 1998 Oct; 20(5):297-302. PubMed ID: 9807677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
    Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
    Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia.
    Sadamori N; Ichiba M; Mine M; Hakariya S; Hayashibara T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
    Br J Haematol; 1995 May; 90(1):100-5. PubMed ID: 7786770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
    Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
    Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.
    Suzuki K; Terui Y; Nishimura N; Mishima Y; Sakajiri S; Yokoyama M; Takahashi S; Tsuyama N; Takeuchi K; Hatake K
    Jpn J Clin Oncol; 2013 Jan; 43(1):37-44. PubMed ID: 23166385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.